Blood Res.  2016 Jun;51(2):142-144. 10.5045/br.2016.51.2.142.

Bilateral myelomatous pleural effusion: presentation of two cases

Affiliations
  • 1Department of Internal Medicine, Western Michigan University, Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA.
  • 2Department of Internal Medicine-Pediatrics, Western Michigan University, Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA.
  • 3Michigan State University, College of Human Medicine, East Lansing, MI, USA.
  • 4Division of Hematology and Oncology, West Michigan Cancer Center, Kalamazoo, MI, USA. schandana@wmcc.org

Abstract

No abstract available.


MeSH Terms

Pleural Effusion*

Figure

  • Fig. 1 Computed tomography image showing extensive bilateral pleural nodularity. A pulmonary mass can be seen on the right anterior chest wall (yellow arrow); bilateral pleural effusions are also present (purple arrows).

  • Fig. 2 Pleural fluid cytology revealing numerous atypical plasmacytoid cells with multinucleated forms, nucleoli, cytoplasmic vacuoles, and mitotic figures.


Reference

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63:11–30. PMID: 23335087.
Article
2. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008; 111:2516–2520. PMID: 17975015.
Article
3. Bladé J, Rosiñol L. Complications of multiple myeloma. Hematol Oncol Clin North Am. 2007; 21:1231–1246. xiPMID: 17996596.
Article
4. Yosunkaya S, Maden E, Toy H, Yazici R, Ozer F, Reisli I. A multiple myeloma case presenting with bilateral pleural involvement. Tuberk Toraks. 2007; 55:285–289. PMID: 17978927.
5. Mikhael JR, Dingli D, Roy V, et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc. 2013; 88:360–376. PMID: 23541011.
Article
6. Kintzer JS Jr, Rosenow EC 3rd, Kyle RA. Thoracic and pulmonary abnormalities in multiple myeloma. A review of 958 cases. Arch Intern Med. 1978; 138:727–730. PMID: 646535.
Article
7. Meoli A, Willsie S, Fiorella R. Myelomatous pleural effusion. South Med J. 1997; 90:65–68. PMID: 9003828.
Article
8. Kamble R, Wilson CS, Fassas A, et al. Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk Lymphoma. 2005; 46:1137–1142. PMID: 16085553.
Article
9. Kim YJ, Kim SJ, Min K, et al. Multiple myeloma with myelomatous pleural effusion: a case report and review of the literature. Acta Haematol. 2008; 120:108–111. PMID: 18957845.
Article
10. Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Suh C. Myelomatous pleural effusion: a case series in a single institution and literature review. Korean J Lab Med. 2011; 31:225–230. PMID: 22016674.
Article
11. Mangiacavalli S, Varettoni M, Zappasodi P, Pica G, Lazzarino M, Corso A. A striking response to bortezomib in a patient with pleural localization of multiple myeloma. Leuk Res. 2009; 33:577–578. PMID: 18842298.
Article
12. Keklik M, Sivgin S, Pala C, et al. Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma. Mediterr J Hematol Infect Dis. 2012; 4:e2012063. PMID: 23170192.
13. Oudart JB, Maquart FX, Semouma O, Lauer M, Arthuis-Demoulin P, Ramont L. Pleural effusion in a patient with multiple myeloma. Clin Chem. 2012; 58:672–674. PMID: 22461512.
Article
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr